lifestyle.eastmnweeklynews.com

Author: UroGen Pharma Ltd.

ZUSDURI™ Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC

February 27, 2026
UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference

February 24, 2026
UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026

February 23, 2026
UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit

February 10, 2026